Detalhe da pesquisa
1.
TLR7/8 Agonist-Loaded Nanoparticles Augment NK Cell-Mediated Antibody-Based Cancer Immunotherapy.
Mol Pharm
; 17(6): 2109-2124, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383885
2.
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing.
Mater Today Bio
; 19: 100567, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36747581
3.
Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer.
Cancers (Basel)
; 12(4)2020 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32295145
4.
Acidic pH-responsive polymer nanoparticles as a TLR7/8 agonist delivery platform for cancer immunotherapy.
Nanoscale
; 10(44): 20851-20862, 2018 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30403212